Financhill
Back

AstraZeneca PLC Quote, Financials, Valuation and Earnings

AstraZeneca PLC Price Quote

$125.46
-2.50 (-1.95%)
(Updated: November 18, 2024 at 5:55 PM ET)

AstraZeneca PLC Key Stats

Sell
36
AstraZeneca PLC (AZNCF) is a Sell

Day range:
$124.55 - $128.70
52-week range:
$118.16 - $175.00
Dividend yield:
2.31%
P/E ratio:
33.59
P/S ratio:
3.90
P/B ratio:
4.87%

Volume:
2.5K
Avg. volume:
1.3K
1-year change:
2.24%
Market cap:
$198.4B
Revenue:
$45.8B
EPS:
$4.17

How Much Does AstraZeneca PLC Make?

Is AstraZeneca PLC Growing As A Company?

  • What Is AstraZeneca PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is AstraZeneca PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.03%

AstraZeneca PLC Stock Price Performance

  • Did AstraZeneca PLC Stock Go Up Last Month?
    AstraZeneca PLC share price went down by -16.75% last month
  • Did AZNCF's Share Price Rise Over The Last Year?
    AZNCF share price rose by 2.24% over the past 1 year

What Is AstraZeneca PLC 52-Week High & Low?

AstraZeneca PLC Price To Free Cash Flow

Is It Risky To Buy AstraZeneca PLC?

  • How Much Debt Does AstraZeneca PLC Have?
    Total long term debt quarterly is $30.1B
  • How Much Cash Does AstraZeneca PLC Have?
    Cash and short term investments quarterly total is $4.9B
  • What Is AstraZeneca PLC’s Book Value Per Share?
    Book value per share is 26.27

Is AstraZeneca PLC Cash Flow Positive?

  • What Is AZNCF Cash Flow From Operations?
    Cash flow from operations (TTM) is $11.3B
  • What Is AstraZeneca PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$3.6B
  • What Is AstraZeneca PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.9B

AstraZeneca PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    AZNCF return on invested capital is 9.41%
  • What Is AstraZeneca PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 6.38%
  • What Is AZNCF Return On Equity?
    ROE is a measure of profitability and is 16.72%

AstraZeneca PLC Earnings Date & Stock Price

AstraZeneca PLC Competitors

  • Who Are AstraZeneca PLC's Competitors?
    Below is a list of companies who compete with AstraZeneca PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • Verona Pharma PLC (VRNA)

AstraZeneca PLC Dividend Yield

AstraZeneca PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 3.41% 0%
Revenue: 18.04% 3.53%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many AZNCF shares are owned by institutional investors?
    799.2M AZNCF shares are owned by institutional investors
  • How many AZNCF shares are owned by insiders?
    0 AZNCF shares are owned by insiders